Insilico studies on anthrax lethal factor inhibitors: Pharmacophore modeling and virtual screening approaches towards designing of novel inhibitors for a killer

详细信息    查看全文

• 作者：Jyoti Roy ; Uday Ch ; ra Kumar ; Pavan Kumar Machiraju ; Ravi Kumar Muttineni ; Suneel Kumar B.V.S ; Rambabu Gundla ; Raveendra Dayam ; Jagarlapudi A.R.P. Sarma
• 关键词：Anthrax ; Lethal factor ; Pharmacophore ; Virtual screening ; Bioweapon
• 刊名：Journal of Molecular Graphics and Modelling
• 出版年：2010
• 出版时间：September 2010
• 年：2010
• 卷：29
• 期：2
• 页码：256-265
• 全文大小：839 K

文摘

Bacillus anthracis is a causative organism of anthrax. The main reason to use anthrax as a bioweapon is the combination of the spore's durability and the lethal toxaemia of the vegetative stage. In anthrax infection, lethal factor (LF) is playing crucial role in causing cell death, by inhibiting pathways that rely on this kinase family. The combination of vaccine and antibiotics is preferred as an effective treatment for this target. Till date, no small molecule inhibitor is identified as a drug on the target. In this study, we have performed pharmacophore modeling and docking studies to identify a novel small molecule inhibitor to target the Anthrax LF. The best pharmacophore model is used to screen 2 M drug-like small molecule database and yielded 2543 hits. Docking studies of the pharmacophore hits on to the active site of Anthrax LF resulted 120 structurally diverse hits. Out of 120 hits, based on synthetic feasibility, 17 hits are selected for further synthesis and pharmacological screening. In due course, we will publish the updated results.